• 患者服务: 与癌共舞小助手
  • 微信号: yagw_help22

QQ登录

只需一步,快速开始

开启左侧

美国研制出能迫使癌细胞自我毁灭的抗癌药物

    [复制链接]
35157 53 小P 发表于 2013-11-10 19:21:32 |
snow0371  初中三年级 发表于 2013-11-11 11:39:00 | 显示全部楼层 来自: 河南郑州
太好了至少有了新的思路和希望。
东南偏东2013  高中一年级 发表于 2013-11-11 15:38:55 | 显示全部楼层 来自: 山东济南
可能是用数学模型的方法分析了各种药物联用的作用,但是用什么样的组合最好,一是不能过早的告诉公众,二是没有经过临床验证的过程,所以,需要等待。但是有常识有胆识的病友可以根据此理论自行试验,也许能摸出一片生天呢
costa_na  大学三年级 发表于 2013-11-12 17:20:33 | 显示全部楼层 来自: 美国


这个是论文的摘要

Sorafenib/Regorafenib and Phosphatidyl Inositol 3 Kinase/Thymoma Viral Proto-Oncogene Inhibition Interact to Kill Tumor Cells
Mol Pharmacol October 2013 84:562-571; published ahead of print July 22, 2013,

Abstract


The present studies were undertaken to determine whether the multikinase inhibitors sorafenib/regorafenib cooperated with clinically relevant , phosphatidyl inositol 3 kinase (PI3K)-thymoma viral proto-oncogene (AKT) inhibitors to kill tumor cells. In liver, colorectal, lung, breast, kidney, and brain cancer cells, at clinically achievable doses, sorafenib/regorafenib and the PI3K inhibitor acetic acid (1S,4E,10R,11R,13S,14R)-[4-diallylaminomethylene-6-hydroxy-1-methoxymethyl-10,13-dimethyl-3,7,17-trioxo-1,3,4,7,10,11,12,13,14,15,16,17-dodecahydro-2-oxa-cyclopenta[a]phenanthren-11-yl ester (PX-866) cooperated in a greater than additive fashion to kill tumor cells. Cells lacking phosphatase and tensin homolog were as sensitive to the drug combination as cells expressing the protein. Similar data were obtained using the AKT inhibitors perifosine and 8-[4-(1-aminocyclobutyl)phenyl]-9-phenyl-1,2,4-triazolo[3,4-f] [1,6]naphthyridin-3(2H)-one hydrochloride (MK2206). PX-866 treatment abolished AKT/glycogen synthase kinase 3 (GSK3) phosphorylation, and cell killing correlated with reduced activity of AKT and mammalian target of rapamycin (mTOR). Expression of activated AKT and to a lesser extent activated mTOR reduced drug combination lethality. Expression of B-cell lymphoma–extra large or dominant negative caspase 9, but not cellular FLICE (FADD-like IL-1b–converting enzyme)-inhibitory protein short, protected cells from the drug combination. Treatment of cells with PX-866 increased protein levels of p62, lysosome-associated membrane protein 2 (LAMP2), and microtubule-associated protein light chain (LC) 3 and LC3II that correlated with a large increase in LC3–green fluorescent protein (GFP) vesicle numbers. Exposure of PX-866 treated cells to sorafenib reduced p62 and LAMP2 levels, decreased the ratio of LC3 to LC3II, and reduced LC3-GFP vesicle levels. Knockdown of Beclin1 or autophagy-related 5 suppressed drug toxicity by ∼40%. In vivo, sorafenib and PX-866 or regorafenib and MK2206 cooperated to suppress the growth of established HuH7 and HCT116 tumors, respectively. Collectively our data demonstrate that the combination of sorafenib family kinase inhibitors with inhibitors of the PI3K/AKT pathway kills tumor cells in vitro and in vivo.

用的是多吉美(索拉菲尼)/瑞格菲尼联合PX-866(PI3K抑制剂)和MK2206(AKT抑制剂)作的体外细胞实验
提到了两种自噬相关的基因:Beclin1和agt5:
Knockdown of Beclin1 or autophagy-related 5 suppressed drug toxicity by ∼40%
敲减Beclin1和atg5抑制了大约40%的药物毒性
这句话不知道怎么理解
憨豆精神  超级版主 发表于 2013-11-12 22:21:28 | 显示全部楼层 来自: 广东广州
即使这理论正确,真能治愈,但自行用现有的药按这理论来联合,将过不了一个瓶颈,就是剂量。假设用多吉美+瑞戈非尼+BKM120+某种药,那么每天的剂量如何设计?各1/4量?那么低的药浓度如何抑制肿瘤靶点?各1/2的量?仍浓度嫌低,且副作用估计也不轻;各3/4的量?这会靠谱,但副作用叠加可能已经很厉害;各足量,想也不敢想……
我是肿瘤病人,不是肿瘤医生;我的一切意见仅供参考,千万别与正规医嘱等同。
欢迎光顾:(http://blog.sina.com.cn/u/5306366644)
小P  大学四年级 发表于 2013-11-13 08:31:52 | 显示全部楼层 来自: 广东肇庆
憨豆精神 发表于 2013-11-12 22:21
即使这理论正确,真能治愈,但自行用现有的药按这理论来联合,将过不了一个瓶颈,就是剂量。假设用多吉美+瑞 ...

谢谢憨豆叔!我是想参照肺癌病人联用BKM120的做法。现阶段靠我们自己去试一个联合用药治愈癌症肯定不行,但通过尝试联合用药延长药物的有效期值得考虑。
明天会更好9999  大学一年级 发表于 2013-11-13 08:41:32 | 显示全部楼层 来自: 吉林吉林
关注。
cgjrg  小学六年级 发表于 2013-11-13 11:44:06 | 显示全部楼层 来自: 广东广州
关注,期待有新的发现.
与癌抗争  初中三年级 发表于 2013-11-14 05:30:07 | 显示全部楼层 来自: 贵州贵阳
关注中,希望成功
为未来  初中一年级 发表于 2013-11-14 15:01:55 | 显示全部楼层 来自: 广东梅州
希望成功,这样爸爸就又有了新的希望
ybbyni121  小学六年级 发表于 2013-11-14 21:22:26 | 显示全部楼层 来自: 浙江台州
持续关注中!!!

发表回复

您需要登录后才可以回帖 登录 | 立即注册

本版积分规则

  • 回复
  • 转播
  • 评分
  • 分享
帮助中心
网友中心
购买须知
支付方式
服务支持
资源下载
售后服务
定制流程
关于我们
关于我们
友情链接
联系我们
关注我们
官方微博
官方空间
微信公号
快速回复 返回顶部 返回列表